2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Huntsman filed supplemental disclosures to its joint proxy statement/prospectus for the proposed merger with Olin, made voluntarily to address lawsuits and demand letters alleging omissions. Huntsman and Olin say the claims are without merit, and the Huntsman stockholder vote is scheduled for August 25, 2026.
Huntsman stockholder and Olin shareholder special meetings are both set for August 25, 2026.
Two New York complaints by Huntsman stockholders were filed July 30, 2026, seeking to enjoin the vote or the merger.
A Missouri complaint by Olin shareholders against Olin, its board and Huntsman was filed as of August 11, 2026.
Supplements add Lazard and Citi analysis details, including net debt of approximately $1,908 million for Huntsman as of March 31, 2026.
Nasdaq notified Helix Acquisition Corp. III on August 14, 2026 that it does not meet the 300 Total Holders requirement for continued listing on the Nasdaq Global Market. The company says the notice is a deficiency notification, not an imminent delisting, and its Class A shares will continue to trade as HLXC.
Nasdaq notice received August 14, 2026 under Listing Rule 5452(a)(2)(A), requiring at least 300 Total Holders
Company has 45 calendar days to submit a plan to regain compliance
If accepted, Nasdaq may grant an extension of up to 180 calendar days from the notice date; otherwise the company may appeal to a Nasdaq Hearings Panel
Nocera's Board concluded on August 14, 2026 that its previously issued 2024 and 2025 annual financial statements and its 2025 quarterly statements should no longer be relied upon because of errors. The company is filing Amendment No. 2 to its 2025 Form 10-K with restated results, which lowers 2024 goodwill and reduces 2025 net sales, while the company has previously disclosed material weaknesses in internal controls.
Board concluded on August 14, 2026 that 2024 and 2025 annual statements and Q1-Q3 2025 interim statements should no longer be relied upon.
2024 goodwill reduced by about $1,351,703, from $2,077,728 to $726,025; accumulated losses at December 31, 2024 increased by about $2,096,572.
2025 net sales reduced by about $2,597,349, offset by lower cost of sales; total 2025 net loss unchanged.
Company cites material weaknesses in internal controls and says remedial measures may not prevent future misstatements.
Teradata's board approved a form of indemnification agreement on August 12, 2026, and entered into it with each director and executive officer. The agreements commit the company to indemnify and advance expenses to each covered person to the fullest extent Delaware law permits, and to cover them under its directors' and officers' insurance policies. The filing is administrative and does not describe any financial figures.
Board approved the form of Indemnification Agreement on August 12, 2026
Agreements cover each Teradata director and executive officer
Teradata will indemnify and advance expenses to the fullest extent permitted under Delaware law
Full terms are in Exhibit 10.1, filed with the 8-K
Lexaria Bioscience Corp. received a letter from Nasdaq on August 17, 2026 confirming that it has regained compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). As a result, the previously requested hearing was cancelled and the company's common stock will continue to be listed and trade on The Nasdaq Capital Market, which removes the near-term risk of delisting for shareholders.
Nasdaq letter dated August 17, 2026 confirmed compliance with the bid price requirement in Listing Rule 5550(a)(2)
Previously requested hearing has been cancelled
Common stock will continue to be listed and trading on The Nasdaq Capital Market
NOAA published a Notice of Intent to prepare an Environmental Impact Statement for TMC USA's USA-B exploration license application, as announced in a press release dated August 17, 2026. The filing describes this as a step in the regulatory process, with a draft EIS, public comment, and a final license decision still to come.
NOAA published the Notice of Intent in the Federal Register; it follows NOAA's certification of the USA-B application on May 26, 2026.
The USA-B application area covers about 122,000 square kilometers of seafloor and an estimated 1.02 billion tonnes of polymetallic nodules.
Next steps named by the company include a NOAA draft EIS and draft terms, conditions and restrictions for public comment, then a final license determination.
The USA-A consolidated application was submitted January 22, 2026 and determined fully compliant April 28, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.